These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2002512)

  • 1. Modifying effects of anticancer drugs adriamycin, actinomycin D, and cisplatin on N-2-fluorenylacetamide-induced hepatocarcinogenesis in male ACI/N rats.
    Tanaka T; Takeuchi T; Shimizu M; Morishita Y; Mori Y; Mori H
    J Toxicol Environ Health; 1991 Mar; 32(3):269-75. PubMed ID: 2002512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of polyprenoic acid (E-5166) on N-2-fluorenylacetamide-initiated hepatocarcinogenesis in rats.
    Shima H; Kuniyasu T; Sugie S; Tanaka T; Mori H; Takahashi M; Muto Y
    Jpn J Cancer Res; 1986 Apr; 77(4):351-5. PubMed ID: 3084425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in gamma-glutamyltransferase activity during N-2-fluorenylacetamide-induced rat hepatocarcinogenesis.
    Capouya ER; Lindahl R
    J Natl Cancer Inst; 1983 Feb; 70(2):359-65. PubMed ID: 6130182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dietary selenium concentration on the development of enzyme-altered liver foci and hepatocellular carcinoma induced by diethylnitrosamine or N-acetylaminofluorene in rats.
    LeBoeuf RA; Laishes BA; Hoekstra WG
    Cancer Res; 1985 Nov; 45(11 Pt 1):5489-95. PubMed ID: 2865004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental studies on hepatic cirrhosis and hepatocarcinogenesis. II. Influence of cirrhotic liver on 2-FAA hepatocarcinogenesis in rats.
    Shimizu A
    Acta Pathol Jpn; 1986 Jul; 36(7):1039-48. PubMed ID: 3529810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing effect of barbital on N-2-fluorenylacetamide-induced rat liver lesions.
    Mori H; Tanaka T; Nishikawa A; Takahashi M; Williams GM
    Gan; 1981 Oct; 72(5):798-801. PubMed ID: 7327380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats.
    Tanaka T; Iwata H; Niwa K; Mori Y; Mori H
    Jpn J Cancer Res; 1988 Dec; 79(12):1297-303. PubMed ID: 2906931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-450 enzyme induction by 5-ethyl-5-phenylhydantoin and 5,5-diethylhydantoin, analogues of barbiturate tumor promoters phenobarbital and barbital, and promotion of liver and thyroid carcinogenesis initiated by N-nitrosodiethylamine in rats.
    Diwan BA; Rice JM; Nims RW; Lubet RA; Hu H; Ward JM
    Cancer Res; 1988 May; 48(9):2492-7. PubMed ID: 3356011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of reserpine on N-2-fluorenylacetamide-induced hepatocarcinogenesis in rats.
    Sugie S; Tanaka T; Kuniyasu T; Mori H
    Toxicol Lett; 1987 Jul; 37(2):115-9. PubMed ID: 3603587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early stages of N-2-fluorenylacetamide-induced hepatocarcinogenesis in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development.
    Katayama S; Ohmori T; Maeura Y; Croci T; Williams GM
    J Natl Cancer Inst; 1984 Jul; 73(1):141-9. PubMed ID: 6588222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Nitroso-N-methylurea initiation in multiple tissues for organ-specific tumor promotion in rats by phenobarbital.
    Diwan BA; Palmer AE; Ohshima M; Rice JM
    J Natl Cancer Inst; 1985 Dec; 75(6):1099-105. PubMed ID: 3865012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ-specific promoting effects of phenobarbital sodium and sodium saccharin in the induction of liver and urinary bladder tumors in male F344 rats.
    Nakanishi K; Fukushima S; Hagiwara A; Tamano S; Ito N
    J Natl Cancer Inst; 1982 Mar; 68(3):497-500. PubMed ID: 6950178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemopreventive effects of melatonin on diethylnitrosamine and phenobarbital-induced hepatocarcinogenesis in male F344 rats.
    Rahman KM; Sugie S; Watanabe T; Tanaka T; Mori H
    Nutr Cancer; 2003; 47(2):148-55. PubMed ID: 15087267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene.
    Maeura Y; Weisburger JH; Williams GM
    Cancer Res; 1984 Apr; 44(4):1604-10. PubMed ID: 6704970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of chlorogenic acid, reserpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamsters.
    Tanaka T; Nishikawa A; Shima H; Sugie S; Shinoda T; Yoshimi N; Iwata H; Mori H
    Basic Life Sci; 1990; 52():429-40. PubMed ID: 2327945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites.
    Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J
    Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of radiation on N-2-fluorenylacetamide-induced hepatocarcinogenesis in male ACI/N rats.
    Mori H; Iwata H; Morishita Y; Mori Y; Ohno T; Tanaka T; Sasaki S
    Jpn J Cancer Res; 1990 Oct; 81(10):975-8. PubMed ID: 2121684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis.
    Préat V; Lans M; de Gerlache J; Taper H; Roberfroid M
    Jpn J Cancer Res; 1986 Jul; 77(7):629-38. PubMed ID: 2875050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of selenium supplementation on hepatocarcinogenesis in rats.
    Aquino TM; Porta EA; Sablan HM; Dorado RD
    Nutr Cancer; 1985; 7(1-2):25-36. PubMed ID: 4070005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute or chronic treatment of rats with N-2-fluorenylacetamide on its N-hydroxylation and on hemoproteins of hepatic microsomes.
    Malejka-Giganti D; Ritter CL
    Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):53-64. PubMed ID: 7394317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.